TELA Bio, Inc. Capital Expenditures Incurred but Not yet Paid
TELA Bio, Inc. (TELA) reported Capital Expenditures Incurred but Not yet Paid of $2.00 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-11.
Financial Statements › Cash Flow › Other Cash Flow Items
us-gaap:CapitalExpendituresIncurredButNotYetPaid · last filed 2026-08-11
- TELA Bio, Inc. capital expenditures incurred but not yet paid for the quarter ending 2025-12-31 was $51.00K.
- TELA Bio, Inc. capital expenditures incurred but not yet paid for the quarter ending 2025-09-30 was -$11.00K, a 109.17% decline year-over-year.
- TELA Bio, Inc. capital expenditures incurred but not yet paid for the quarter ending 2024-09-30 was $120.00K.
- TELA Bio, Inc. capital expenditures incurred but not yet paid for the quarter ending 2024-06-30 was -$121.00K, a 490.32% decline year-over-year.
- TELA Bio, Inc. capital expenditures incurred but not yet paid for fiscal 2025 was $66.00K.
- TELA Bio, Inc. capital expenditures incurred but not yet paid for fiscal 2023 was $119.00K, a 1600.00% increase from fiscal 2022.
- TELA Bio, Inc. capital expenditures incurred but not yet paid for fiscal 2022 was $7.00K, a 95.78% decline from fiscal 2021.
- TELA Bio, Inc. capital expenditures incurred but not yet paid for fiscal 2021 was $166.00K, a 5433.33% increase from fiscal 2020.
| Period end | Capital Expenditures Incurred but Not yet Paid 3 month | Capital Expenditures Incurred but Not yet Paid 6 month | Capital Expenditures Incurred but Not yet Paid 9 month | Capital Expenditures Incurred but Not yet Paid 12 month |
|---|---|---|---|---|
| 2026-06-30 | $2.00K 10-Q · filed 2026-08-11 | |||
| 2025-12-31 | $51.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-25 | $40.00K derived: sum of 2 quarters · filed 2026-03-25 | $66.00K 10-K · filed 2026-03-25 | |
| 2025-09-30 | -$11.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-14 | $15.00K 10-Q · filed 2025-11-14 | ||
| 2025-06-30 | $26.00K 10-Q · filed 2026-08-11 | |||
| 2024-09-30 | $120.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-14 | -$1.00K derived: sum of 2 quarters · filed 2025-11-14 | $175.00K 10-Q · filed 2025-11-14 | $271.00K derived: sum of 4 quarters · filed 2026-03-25 |
| 2024-06-30 | -$121.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-11 | $55.00K 10-Q · filed 2025-08-11 | $151.00K derived: sum of 3 quarters · filed 2026-03-25 | $125.00K derived: sum of 4 quarters · filed 2026-03-25 |
| 2024-03-31 | $176.00K 10-Q · filed 2025-05-08 | $272.00K derived: sum of 2 quarters · filed 2026-03-25 | $246.00K derived: sum of 3 quarters · filed 2026-03-25 | $277.00K derived: sum of 4 quarters · filed 2026-03-25 |
| 2023-12-31 | $96.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-25 | $70.00K derived: sum of 2 quarters · filed 2026-03-25 | $101.00K derived: sum of 3 quarters · filed 2026-03-25 | $119.00K 10-K · filed 2026-03-25 |
| 2023-09-30 | -$26.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-08 | $5.00K derived: sum of 2 quarters · filed 2024-11-08 | $23.00K 10-Q · filed 2024-11-08 | $22.00K derived: sum of 4 quarters · filed 2025-03-21 |
| 2023-06-30 | $31.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-13 | $49.00K 10-Q · filed 2024-08-13 | $48.00K derived: sum of 3 quarters · filed 2025-03-21 | -$90.00K derived: sum of 4 quarters · filed 2025-03-21 |
| 2023-03-31 | $18.00K 10-Q · filed 2024-05-10 | $17.00K derived: sum of 2 quarters · filed 2025-03-21 | -$121.00K derived: sum of 3 quarters · filed 2025-03-21 | $9.00K derived: sum of 4 quarters · filed 2025-03-21 |
| 2022-12-31 | -$1.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-21 | -$139.00K derived: sum of 2 quarters · filed 2025-03-21 | -$9.00K derived: sum of 3 quarters · filed 2025-03-21 | $7.00K 10-K · filed 2025-03-21 |
| 2022-09-30 | -$138.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-13 | -$8.00K derived: sum of 2 quarters · filed 2023-11-13 | $8.00K 10-Q · filed 2023-11-13 | $77.00K derived: sum of 4 quarters · filed 2024-03-22 |
| 2022-06-30 | $130.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-10 | $146.00K 10-Q · filed 2023-08-10 | $215.00K derived: sum of 3 quarters · filed 2024-03-22 | $257.00K derived: sum of 4 quarters · filed 2024-03-22 |
| 2022-03-31 | $16.00K 10-Q · filed 2023-05-11 | $85.00K derived: sum of 2 quarters · filed 2024-03-22 | $127.00K derived: sum of 3 quarters · filed 2024-03-22 | |
| 2021-12-31 | $69.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-22 | $111.00K derived: sum of 2 quarters · filed 2024-03-22 | $166.00K 10-K · filed 2024-03-22 | |
| 2021-09-30 | $42.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-10 | $97.00K 10-Q · filed 2022-11-10 | ||
| 2021-06-30 | $55.00K 10-Q · filed 2022-08-11 | |||
| 2020-12-31 | -$1.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-23 | $3.00K 10-K · filed 2023-03-23 | ||
| 2020-09-30 | $4.00K 10-Q · filed 2021-11-12 | |||
| 2020-03-31 | $4.00K 10-Q · filed 2021-05-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Xtant Medical Holdings, Inc. (XTNT) | United States | $0.053B | |
| Spectral AI, Inc. (MDAI) | United States | $0.052B | |
| Sensus Healthcare, Inc. (SRTS) | United States | $0.048B | -3.24 |
| DarioHealth Corp. (DRIO) | $0.066B | -1.39 | |
| CVRx, Inc. (CVRX) | United States | $0.067B | -2.62 |
| NEPHROS INC (NEPH) | United States | $0.046B | 23.02 |
| SANUWAVE Health, Inc. (SNWV) | United States | $0.041B | 5.47 |
| FRACTYL HEALTH, INC. (GUTS) | United States | $0.075B | -1.18 |
| RenovoRx, Inc. (RNXT) | United States | $0.076B | -3.62 |
| InspireMD, Inc. (NSPR) | $0.033B |